Diabetes Clinical Trials in Miami

Showing 81-100 of 453 trials

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

NCT04886388

BT-001 is a software program intended to help patients with type 2 diabetes, under the guidance of their physician, improve glycemic control (i.e., levels of blood sugar). The BT-001 software delivers a type of behavioral therapy to patients via a mobile application that targets behaviors related to achieving glycemic control. The effectiveness of BT-001 will be measured by its ability to help patients reduce Hemoglobin A1c, or HbA1c (a marker in the blood that measures blood sugar) compared to standard medical care in patients with type 2 diabetes.

Type 2 Diabetes

Better Therapeutics668 participantsStarted Apr 2021

San Francisco, California, United States • Miami, Florida, United States • Atlanta, Georgia, United States +3 more locations

COMPLETEDPhase 1/2< 1 mile

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

NCT03751007

The purpose of this study is to assess the safety and tolerability of different doses of AG019 administered alone or in combination with teplizumab in participants with recent-onset type 1 diabetes (T1D).

Diabetes type1

Precigen Actobio T1D, LLC45 participantsStarted Oct 2018

Birmingham, Alabama, United States • San Francisco, California, United States • Ventura, California, United States +15 more locations

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recent-onset Diagnosed Type 1 Diabetes (T1D)

Diabetes Trials in Other Cities

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only

Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus

Sotagliflozin Bioequivalence Study

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

StatStrip Glucose/Ketone Meter System Ketone Evaluation

Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus

mRNA Based-Covid-19 Vaccine Effects on Blood Glucose Levels

The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus

A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes

A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.

The Effect of In-utero Exposure to Metformin in 5-11 Year Old Offspring of Mothers in the MiTy Trial

Other Conditions in Miami